Lexaria Bioscience Corp. (LEXX)

Lexaria Bioscience Cash Flow Statement

Financials in millions USD. Fiscal year is September - August.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 28, 2026	Aug 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021
Net Income	-9.53	-11.9	-5.8	-6.66	-7.27	-4.03
Depreciation & Amortization	0.12	0.12	0.11	0.19	0.14	0.15
Asset Writedown & Restructuring Costs	0.21	0.25	0.06	0.11	-	-
Loss (Gain) From Sale of Investments	0.07	0.03	0.07	0.22	0.76	0.17
Stock-Based Compensation	0.74	0.86	0.49	0.17	1.95	1.28
Provision & Write-off of Bad Debts	-	-	0.01	-	-	0.05
Other Operating Activities	-0	-0	-0.01	-0.05	-0.12	-0.15
Change in Accounts Receivable	0.29	-0.21	-0.04	0.03	-0.14	0.19
Change in Inventory	-	-	-	0.04	-0	0.1
Change in Accounts Payable	-1.61	0.4	0.83	0.09	0.05	0.01
Change in Unearned Revenue	0	-0	0	-	-	-0.04
Change in Other Net Operating Assets	0.33	0.02	-0.69	-0.01	-0.26	-0.19
Operating Cash Flow	-9.37	-10.45	-4.96	-5.88	-4.88	-3.99
Capital Expenditures	-0.04	-0.02	-0.04	-0.03	-0.05	-
Sale of Property, Plant & Equipment	-	-	-	-	-	0.27
Sale (Purchase) of Intangibles	-0.05	-0.08	-0.15	-0.14	-0.13	-0.08
Investment in Securities	-0.14	-0.14	-	-	-	-
Investing Cash Flow	-0.24	-0.24	-0.19	-0.17	-0.18	0.19
Long-Term Debt Repaid	-	-	-	-	-0.04	-0.07
Net Debt Issued (Repaid)	-	-	-	-	-0.04	-0.07
Issuance of Common Stock	8.21	6.05	10.32	1.59	-	13.49
Financing Cash Flow	8.21	6.05	10.32	1.59	-0.04	13.42
Foreign Exchange Rate Adjustments	0.06	-0.05	-0.02	-	-	-
Net Cash Flow	-1.34	-4.7	5.15	-4.46	-5.1	9.62
Free Cash Flow	-9.42	-10.48	-5	-5.91	-4.93	-3.99
Free Cash Flow Margin	-2558.49%	-1483.88%	-1077.38%	-2614.84%	-1929.75%	-552.02%
Free Cash Flow Per Share	-0.45	-0.58	-0.40	-0.89	-0.84	-0.91
Cash Income Tax Paid	0	-	-	0.01	-0	-0.02
Levered Free Cash Flow	-5.93	-6.16	-2.98	-3.6	-2.3	-2.37
Unlevered Free Cash Flow	-5.93	-6.16	-2.98	-3.6	-2.3	-2.37
Change in Working Capital	-0.99	0.2	0.11	0.14	-0.35	0.06

Updated Feb 28, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q